CC BY 4.0 · Aorta (Stamford) 2022; 10(05): 235-241
DOI: 10.1055/s-0042-1750097
Original Research Article

Evaluating the Effectiveness of Stenting for Aortic Coarctation

Constantinos Contrafouris
1   1st Cardiac Surgery Department, “Onassis” Cardiac Surgery Center, Athens, Greece
,
Constantine N. Antonopoulos
2   Department of Vascular Surgery, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece
,
Spyridon Rammos
3   Department of Pediatric Cardiology, “Onassis” Cardiac Surgery Center, Athens, Greece
,
Meletios Kanakis
4   Department of Pediatric and Congenital Heart Surgery, “Onassis” Cardiac Surgery Center, Athens, Greece
,
Konstantinos Petsios
5   Nursing Clinical Research Office, “Onassis” Cardiac Surgery Center, Athens, Greece
,
John D. Kakisis
2   Department of Vascular Surgery, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece
,
George Geroulakos
2   Department of Vascular Surgery, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece
› Author Affiliations
Funding None.

Abstract

Background Coarctation of the aorta (CoA) is a congenital cardiovascular malformation involving narrowing of the thoracic aorta just distal to the left subclavian artery. The aim of our study was to evaluate the hemodynamic effects of endovascular treatment for CoA by using invasive aortic catheterization.

Methods All patients with CoA who underwent treatment by aortic stent implantation between September 1, 2003, and February 1, 2019, at the “Onassis Cardiac Surgery Center,” in Athens, Greece, were evaluated. Patients were treated with either bare (uncovered) Cheatham-Platinum (bCP) or covered Cheatham-Platinum (cCP) stent implantations. Invasive aortic pressure measurements were recorded before and after the endovascular intervention.

Results A total of 48, eight zig CP stents, comprising 24 bCP and 24 cCP stents were implanted in 47 patients. The mean aortic diameter (mm) at the CoA lesion increased from 9.7 ± 3.3 to 19.2 ± 2.9 mm (p <0.01) after the endovascular procedure. The invasive mean blood pressure (BP; mm Hg) from catheterization in the descending aorta increased (before = 114.2 ± 12.8 vs. after = 135.5 ± 28.1; p <0.01), while the invasive mean BP (mm Hg) from catheterization in the ascending aorta was decreased (before = 156.8 ± 25.0 vs. after = 138.4 ± 27.5; p <0.01) after the intervention. The mean aortic BP gradient decreased in both types of stents after intervention (BP gradient among patients with cCP stents = 30.9 +/− 23.6 mmHg and BP gradient among patients with bCP stents = 38.0 +/−23.1 mmHg). However, there was no statistically significant difference between the two types of stents; p = 0.36.

Conclusions Invasive aortic catheterization provided evidence that endovascular stenting with either bare or covered stents is efficient in treating patients with CoA.



Publication History

Received: 30 May 2021

Accepted: 27 March 2022

Article published online:
20 December 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Verheugt CL, Uiterwaal CS, Grobbee DE, Mulder BJ. Long-term prognosis of congenital heart defects: a systematic review. Int J Cardiol 2008; 131 (01) 25-32
  • 2 Stout KK, Daniels CJ, Aboulhosn JA. et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139 (14) e637-e697
  • 3 Wheatley III GH, Koullias GJ, Rodriguez-Lopez JA, Ramaiah VG, Diethrich EB. Is endovascular repair the new gold standard for primary adult coarctation?. Eur J Cardiothorac Surg 2010; 38 (03) 305-310
  • 4 Cheatham JP. Stenting of coarctation of the aorta. Catheter Cardiovasc Interv 2001; 54 (01) 112-125
  • 5 Qureshi AM, McElhinney DB, Lock JE, Landzberg MJ, Lang P, Marshall AC. Acute and intermediate outcomes, and evaluation of injury to the aortic wall, as based on 15 years experience of implanting stents to treat aortic coarctation. Cardiol Young 2007; 17 (03) 307-318
  • 6 Taylor PR, Gaines PA, McGuinness CL. et al. Thoracic aortic stent grafts–early experience from two centres using commercially available devices. Eur J Vasc Endovasc Surg 2001; 22 (01) 70-76
  • 7 Pedra CA, Fontes VF, Esteves CA. et al. Use of covered stents in the management of coarctation of the aorta. Pediatr Cardiol 2005; 26 (04) 431-439
  • 8 Ewert P, Berger F, Kretschmar O. et al. Stent implantation as therapy of first choice in adults with coarctation. Z Kardiol 2003; 92 (01) 48-52
  • 9 Tanous D, Collins N, Dehghani P, Benson LN, Horlick EM. Covered stents in the management of coarctation of the aorta in the adult: initial results and 1-year angiographic and hemodynamic follow-up. Int J Cardiol 2010; 140 (03) 287-295
  • 10 Butera G, Piazza L, Chessa M. et al. Covered stents in patients with complex aortic coarctations. Am Heart J 2007; 154 (04) 795-800
  • 11 Forbes TJ, Kim DW, Du W. et al; CCISC Investigators. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol 2011; 58 (25) 2664-2674
  • 12 Forbes TJ, Garekar S, Amin Z. et al; Congenital Cardiovascular Interventional Study Consortium (CCISC). Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv 2007; 70 (02) 276-285
  • 13 Meadows J, Minahan M, McElhinney DB, McEnaney K, Ringel R. COAST Investigators*. Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST). Circulation 2015; 131 (19) 1656-1664
  • 14 Torok RD, Campbell MJ, Fleming GA, Hill KD. Coarctation of the aorta: Management from infancy to adulthood. World J Cardiol 2015; 7 (11) 765-775
  • 15 Tzifa A, Ewert P, Brzezinska-Rajszys G. et al. Covered Cheatham-platinum stents for aortic coarctation: early and intermediate-term results. J Am Coll Cardiol 2006; 47 (07) 1457-1463
  • 16 Lock JE, Bass JL, Amplatz K, Fuhrman BP, Castaneda-Zuniga W. Balloon dilation angioplasty of aortic coarctations in infants and children. Circulation 1983; 68 (01) 109-116
  • 17 English KM. Stenting the mildly obstructive aortic arch: useful treatment or oculo-inflatory reflex?. Heart 2006; 92 (11) 1541-1543
  • 18 Chang ZP, Jiang SL, Xu ZY. et al. Use of covered Cheatham-Platinum stent as the primary modality in the treatment for native coarctation of the aorta. Chin Med J (Engl) 2012; 125 (06) 1005-1009
  • 19 Morgan GJ, Lee KJ, Chaturvedi R, Bradley TJ, Mertens L, Benson L. Systemic blood pressure after stent management for arch coarctation implications for clinical care. JACC Cardiovasc Interv 2013; 6 (02) 192-201
  • 20 Godart F. Intravascular stenting for the treatment of coarctation of the aorta in adolescent and adult patients. Arch Cardiovasc Dis 2011; 104 (12) 627-635
  • 21 Pedra CA, Fontes VF, Esteves CA. et al. Stenting vs. balloon angioplasty for discrete unoperated coarctation of the aorta in adolescents and adults. Catheter Cardiovasc Interv 2005; 64 (04) 495-506
  • 22 O'Sullivan J. Late hypertension in patients with repaired aortic coarctation. Curr Hypertens Rep 2014; 16 (03) 421